Article thumbnail

Novel drugs that target the metabolic reprogramming in renal cell cancer

By Johannes C. van der Mijn, David J. Panka, Andrew K. Geissler, Henk. M. Verheul and James W. Mier
Publisher: Springer Nature
Year: 2016
DOI identifier: 10.1186/s40170-016-0154-8
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.